Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mikra sells over-the-counter nutraceutical supplements (not approved pharmaceuticals) aimed at improving cellular health, energy, cognition, and inflammation. Its flagship product CELLF is described as a novel cellular therapeutic compound using bioactive ingredients and a patented transferrin glycoprotein delivery mechanism. The company has conducted pre-clinical genomic studies and multiple clinical/consumer trials but does not have regulated drug clinical trial results in the pharma sense.[3][5]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mikra Cellular Sciences.